December 7, 2010 -- Bioo Scientific announced today that it has been awarded a grant of $150,000 from the National Science Foundation to support its research for the biomolecular detection of microRNA. Changes in microRNA (miRNA) expression have been shown to be associated with a variety of normal physiological processes as well as diseases including cancer. This funding will allow Bioo Scientific to develop a rapid, quantitative technology to measure miRNA expression in living cells or tumor tissue.
According to Dr. Masoud Toloue, Senior Scientist at Bioo Scientific, “Most cancer diagnostic tests tend to focus on proteins expressed from oncogenes which do not lend well to early detection. With the recent classification of certain microRNAs as anti-tumorigenic or oncogenic, our work will be centered on developing diagnostic markers from these non-coding genes. Our ultimate goal will be to quickly assess microRNA profiles from a patient’s tissue.”
About Bioo Scientific Corporation
Bioo Scientific Corporation is an Austin, TX based biotechnology company that provides innovative solutions to the life science industry. Bioo Scientific’s products are used around the world and can be purchased both directly or through our global distribution network that markets our products in more than 60 countries. For more information about Bioo Scientific, visit www.biooscientific.com.
